Derepression of pathological cardiac genes by members of the CaM kinase superfamily

Cardiovascular Research

Volumn 73, Issue 4, 2007, Pages 667-677

  McKinsey, Timothy A ^a  

^a Myogen Inc   (United States)

Author keywords

CaM kinase; Chromatin; Histone deacetylase; Signaling; Transcription

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE 5; HISTONE DEACETYLASE 7; HISTONE DEACETYLASE 9; HISTONE DEACETYLASE IIA; MICROTUBULE AFFINITY REGULATING KINASE 1; MICROTUBULE AFFINITY REGULATING KINASE 2; MICROTUBULE AFFINITY REGULATING KINASE 3; MICROTUBULE AFFINITY REGULATING KINASE 4; MICROTUBULE ASSOCIATED KINASE; MYOCYTE ENHANCER FACTOR 2; PHOSPHOTRANSFERASE; PROTEIN 14 3 3; PROTEIN CDC25C; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN KINASE C LAMBDA; PROTEIN KINASE D; PROTEIN TYROSINE PHOSPHATASE; SUMO PROTEIN; TRANSCRIPTION FACTOR GATA 4; UBIQUITIN; UNCLASSIFIED DRUG;

CELL DEATH; DISEASE COURSE; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; SYSTEMATIC REVIEW;

ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARDIOMEGALY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HISTONE DEACETYLASES; HUMANS; MYOCARDIUM; PROTEIN KINASE C; VENTRICULAR REMODELING;

EID: 33846889551     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.11.036     Document Type: Review

References (126)

1. Mann D.L., and Bristow M.R. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 111 (2005) 2837-2849
2. Manning G., Whyte D.B., Martinez R., Hunter T., and Sudarsanam S. The protein kinase complement of the human genome. Science 298 (2002) 1912-1934
3. Jenuwein T., and Allis C.D. Translating the histone code. Science 293 (2001) 1074-1080
4. Miyamoto S., Kawamura T., Morimoto T., Ono K., Wada H., Kawase Y., et al. Histone acetyltransferase activity of p300 is required for the promotion of left ventricular remodeling after myocardial infarction in adult mice in vivo. Circulation 113 (2006) 679-690
5. Kim M.S., Merlo X., Wilson C., and Lough J. Co-activation of atrial natriuretic factor promoter by Tip60 and serum response factor. J Biol Chem 281 (2006) 15082-15089
6. Davidson S.M., Townsend P.A., Carroll C., Yurek-George A., Balasubramanyam K., Kundu T.K., et al. The transcriptional coactivator p300 plays a critical role in the hypertrophic and protective pathways induced by phenylephrine in cardiac cells but is specific to the hypertrophic effect of urocortin. Chembiochem 6 (2005) 162-170
7. Shilatifard A. Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu Rev Biochem 75 (2006) 243-269
8. Glozak M.A., Sengupta N., Zhang X., and Seto E. Acetylation and deacetylation of non-histone proteins. Gene 363 (2005) 15-23
9. Yanazume T., Hasegawa K., Morimoto T., Kawamura T., Wada H., Matsumori A., et al. Cardiac p300 is involved in myocyte growth with decompensated heart failure. Mol Cell Biol 23 (2003) 3593-3606
10. Ma K., Chan J.K., Zhu G., and Wu Z. Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation. Mol Cell Biol 25 (2005) 3575-3582
11. Verdin E., Dequiedt F., and Kasler H.G. Class II histone deacetylases: versatile regulators. Trends Genet 19 (2003) 286-293
12. Yang X.J., and Seto E. Collaborative spirit of histone deacetylases in regulating chromatin structure and gene expression. Curr Opin Genet Dev 13 (2003) 143-153
13. Antos C.L., McKinsey T.A., Dreitz M., Hollingsworth L.M., Zhang C.L., Schreiber K., et al. Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors. J Biol Chem 278 (2003) 28930-28937
14. Kee H.J., Sohn I.S., Nam K.I., Park J.E., Qian Y.R., Yin Z., et al. Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding. Circulation 113 (2006) 51-59
15. Kong Y., Tannous P., Lu G., Berenji K., Rothermel B.A., Olson E.N., et al. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation 113 (2006) 2579-2588
16. Kook H., Lepore J.J., Gitler A.D., Lu M.M., Wing-Man Y.W., Mackay J., et al. Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop. J Clin Invest 112 (2003) 863-871
17. Hubbert C., Guardiola A., Shao R., Kawaguchi Y., Ito A., Nixon A., et al. HDAC6 is a microtubule-associated deacetylase. Nature 417 (2002) 455-458
18. Longo V.D., and Kennedy B.K. Sirtuins in aging and age-related disease. Cell 126 (2006) 257-268
19. Chen I.Y., Lypowy J., Pain J., Sayed D., Grinberg S., Alcendor R.R., et al. Histone H2A.z is essential for cardiac myocyte hypertrophy but opposed by silent information regulator 2alpha. J Biol Chem 281 (2006) 19369-19377
20. Alcendor R.R., Kirshenbaum L.A., Imai S., Vatner S.F., and Sadoshima J. Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes. Circ Res 95 (2004) 971-980
21. Lemercier C., Verdel A., Galloo B., Curtet S., Brocard M.P., and Khochbin S. mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity. J Biol Chem 275 (2000) 15594-15599
22. Lu J., McKinsey T.A., Nicol R.L., and Olson E.N. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc Natl Acad Sci U S A 97 (2000) 4070-4075
23. Miska E.A., Karlsson C., Langley E., Nielsen S.J., Pines J., and Kouzarides T. HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J 18 (1999) 5099-5107
24. Sparrow D.B., Miska E.A., Langley E., Reynaud-Deonauth S., Kotecha S., Towers N., et al. MEF-2 function is modified by a novel co-repressor, MITR. EMBO J 18 (1999) 5085-5098
25. Wang A.H., Bertos N.R., Vezmar M., Pelletier N., Crosato M., Heng H.H., et al. HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Mol Cell Biol 19 (1999) 7816-7827
26. Kolodziejczyk S.M., Wang L., Balazsi K., DeRepentigny Y., Kothary R., and Megeney L.A. MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium. Curr Biol 9 (1999) 1203-1206
27. Lu J., McKinsey T.A., Nicol R.L., and Olson E.N. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc Natl Acad Sci U S A 97 (2000) 4070-4075
28. Passier R., Zeng H., Frey N., Naya F.J., Nicol R.L., McKinsey T.A., et al. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J Clin Invest 105 (2000) 1395-1406
29. Zhang C.L., McKinsey T.A., Chang S., Antos C.L., Hill J.A., and Olson E.N. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110 (2002) 479-488
30. Xu J., Gong N.L., Bodi I., Aronow B.J., Backx P.H., and Molkentin J.D. Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice. J Biol Chem 281 (2006) 9152-9162
31. Backs J., Song K., Bezprozvannaya S., Chang S., and Olson E.N. CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J Clin Invest 116 (2006) 1853-1864
32. Bush E., Fielitz J., Melvin L., Martinez-Arnold M., McKinsey T.A., Plichta R., et al. A small molecular activator of cardiac hypertrophy uncovered in a chemical screen for modifiers of the calcineurin signaling pathway. Proc Natl Acad Sci U S A 101 (2004) 2870-2875
33. Vega R.B., Harrison B.C., Meadows E., Roberts C.R., Papst P.J., Olson E.N., et al. Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol Cell Biol 24 (2004) 8374-8385
34. Chang S., McKinsey T.A., Zhang C.L., Richardson J.A., Hill J.A., and Olson E.N. Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Mol Cell Biol 24 (2004) 8467-8476
35. Vega R.B., Matsuda K., Oh J., Barbosa A.C., Yang X., Meadows E., et al. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119 (2004) 555-566
36. Chang S., Young B.D., Li S., Qi X., Richardson J.A., and Olson E.N. Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10. Cell 126 (2006) 321-334
37. Davis F.J., Gupta M., Camoretti-Mercado B., Schwartz R.J., and Gupta M.P. Calcium/calmodulin-dependent protein kinase activates serum response factor transcription activity by its dissociation from histone deacetylase, HDAC4. Implications in cardiac muscle gene regulation during hypertrophy. J Biol Chem 278 (2003) 20047-20058
38. Xing W., Zhang T.C., Cao D., Wang Z., Antos C.L., Li S., et al. Myocardin induces cardiomyocyte hypertrophy. Circ Res 98 (2006) 1089-1097
39. Dai Y.S., Xu J., and Molkentin J.D. The DnaJ-related factor Mrj interacts with nuclear factor of activated T cells c3 and mediates transcriptional repression through class II histone deacetylase recruitment. Mol Cell Biol 25 (2005) 9936-9948
40. Song K., Backs J., McAnally J., Qi X., Gerard R.D., Richardson J.A., et al. The transcriptional coactivator CAMTA2 stimulates cardiac growth by opposing class II histone deacetylases. Cell 125 (2006) 453-466
41. Akazawa H., and Komuro I. Roles of cardiac transcription factors in cardiac hypertrophy. Circ Res 92 (2003) 1079-1088
42. Zhang C.L., McKinsey T.A., and Olson E.N. The transcriptional corepressor MITR is a signal-responsive inhibitor of myogenesis. Proc Natl Acad Sci U S A 98 (2001) 7354-7359
43. Zhou X., Richon V.M., Rifkind R.A., and Marks P.A. Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5. Proc Natl Acad Sci U S A 97 (2000) 1056-1061
44. Zhang C.L., McKinsey T.A., Lu J.R., and Olson E.N. Association of COOH-terminal-binding protein (CtBP) and MEF2-interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor. J Biol Chem 276 (2001) 35-39
45. Zhang C.L., McKinsey T.A., and Olson E.N. Association of class II histone deacetylases with heterochromatin protein 1: potential role for histone methylation in control of muscle differentiation. Mol Cell Biol 22 (2002) 7302-7312
46. Fischle W., Dequiedt F., Fillion M., Hendzel M.J., Voelter W., and Verdin E. Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo. J Biol Chem 276 (2001) 35826-35835
47. Fischle W., Dequiedt F., Hendzel M.J., Guenther M.G., Lazar M.A., Voelter W., et al. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol Cell 9 (2002) 45-57
48. Harrison B.C., Roberts C.R., Hood D.B., Sweeney M., Gould J.M., Bush E.W., et al. The CRM1 nuclear export receptor controls pathological cardiac gene expression. Mol Cell Biol 24 (2004) 10636-10649
49. McKinsey T.A., Zhang C.L., Lu J., and Olson E.N. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408 (2000) 106-111
50. McKinsey T.A., Zhang C.L., and Olson E.N. Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proc Natl Acad Sci U S A 97 (2000) 14400-14405
51. Rozengurt E., Rey O., and Waldron R.T. Protein kinase D signaling. J Biol Chem 280 (2005) 13205-13208
52. Johannes F.J., Prestle J., Eis S., Oberhagemann P., and Pfizenmaier K. PKCu is a novel, atypical member of the protein kinase C family. J Biol Chem 269 (1994) 6140-6148
53. Valverde A.M., Sinnett-Smith J., Van L.J., and Rozengurt E. Molecular cloning and characterization of protein kinase D: a target for diacylglycerol and phorbol esters with a distinctive catalytic domain. Proc Natl Acad Sci U S A 91 (1994) 8572-8576
54. Iglesias T., and Rozengurt E. Protein kinase D activation by mutations within its pleckstrin homology domain. J Biol Chem 273 (1998) 410-416
55. Iglesias T., and Rozengurt E. Protein kinase D activation by deletion of its cysteine-rich motifs. FEBS Lett 454 (1999) 53-56
56. Huynh Q.K., and McKinsey T.A. Protein kinase D directly phosphorylates histone deacetylase 5 via a random sequential kinetic mechanism. Arch Biochem Biophys 450 (2006) 141-148
57. Chang S., Bezprozvannaya S., Li S., and Olson E.N. An expression screen reveals modulators of class II histone deacetylase phosphorylation. Proc Natl Acad Sci U S A 102 (2005) 8120-8125
58. Dequiedt F., Van L.J., Lecomte E., Van D.V., Seufferlein T., Vandenheede J.R., et al. Phosphorylation of histone deacetylase 7 by protein kinase D mediates T cell receptor-induced Nur77 expression and apoptosis. J Exp Med 201 (2005) 793-804
59. Parra M., Kasler H., McKinsey T.A., Olson E.N., and Verdin E. Protein kinase D1 phosphorylates HDAC7 and induces its nuclear export after T-cell receptor activation. J Biol Chem 280 (2005) 13762-13770
60. Harrison B.C., Kim M.S., van R.E., Plato C.F., Papst P.J., Vega R.B., et al. Regulation of cardiac stress signaling by protein kinase D1. Mol Cell Biol 26 (2006) 3875-3888
61. Matthews S.A., Liu P., Spitaler M., Olson E.N., McKinsey T.A., Cantrell D.A., et al. Essential role for protein kinase D family kinases in the regulation of class II histone deacetylases in B lymphocytes. Mol Cell Biol 26 (2006) 1569-1577
62. Haworth R.S., Goss M.W., Rozengurt E., and Avkiran M. Expression and activity of protein kinase D/protein kinase C mu in myocardium: evidence for alpha1-adrenergic receptor-and protein kinase C-mediated regulation. J Mol Cell Cardiol 32 (2000) 1013-1023
63. Yuan J., Slice L.W., and Rozengurt E. Activation of protein kinase D by signaling through Rho and the alpha subunit of the heterotrimeric G protein G13. J Biol Chem 276 (2001) 38619-38627
64. Yuan J., Slice L.W., Gu J., and Rozengurt E. Cooperation of Gq, Gi, and G12/13 in protein kinase D activation and phosphorylation induced by lysophosphatidic acid. J Biol Chem 278 (2003) 4882-4891
65. Liao J.K. Statin therapy for cardiac hypertrophy and heart failure. J Investig Med 52 (2004) 248-253
66. Auer A., Von B.J., Sturany S., von W.G., Van L.J., Vandenheede J., et al. Role of the regulatory domain of protein kinase D2 in phorbol ester binding, catalytic activity, and nucleocytoplasmic shuttling. Mol Biol Cell 16 (2005) 4375-4385
67. Rey O., Sinnett-Smith J., Zhukova E., and Rozengurt E. Regulated nucleocytoplasmic transport of protein kinase D in response to G protein-coupled receptor activation. J Biol Chem 276 (2001) 49228-49235
68. Rey O., Yuan J., Young S.H., and Rozengurt E. Protein kinase C nu/protein kinase D3 nuclear localization, catalytic activation, and intracellular redistribution in response to G protein-coupled receptor agonists. J Biol Chem 278 (2003) 23773-23785
69. Waldron R.T., Rey O., Iglesias T., Tugal T., Cantrell D., and Rozengurt E. Activation loop Ser744 and Ser748 in protein kinase D are transphosphorylated in vivo. J Biol Chem 276 (2001) 32606-32615
70. Waldron R.T., and Rozengurt E. Protein kinase C phosphorylates protein kinase D activation loop Ser744 and Ser748 and releases autoinhibition by the pleckstrin homology domain. J Biol Chem 278 (2003) 154-163
71. Wong C., and Jin Z.G. Protein kinase C-dependent protein kinase D activation modulates ERK signal pathway and endothelial cell proliferation by vascular endothelial growth factor. J Biol Chem 280 (2005) 33262-33269
72. Dorn G.W., and Force T. Protein kinase cascades in the regulation of cardiac hypertrophy. J Clin Invest 115 (2005) 527-537
73. Wood C.D., Marklund U., and Cantrell D.A. Dual phospholipase C/diacylglycerol requirement for protein kinase D1 activation in lymphocytes. J Biol Chem 280 (2005) 6245-6251
74. Storz P., Doppler H., Johannes F.J., and Toker A. Tyrosine phosphorylation of protein kinase D in the pleckstrin homology domain leads to activation. J Biol Chem 278 (2003) 17969-17976
75. Storz P., and Toker A. Protein kinase D mediates a stress-induced NF-kappaB activation and survival pathway. EMBO J 22 (2003) 109-120
76. Jamora C., Yamanouye N., Van L.J., Laudenslager J., Vandenheede J.R., Faulkner D.J., et al. Gbetagamma-mediated regulation of Golgi organization is through the direct activation of protein kinase D. Cell 98 (1999) 59-68
77. Carnegie G.K., Smith F.D., McConnachie G., Langeberg L.K., and Scott J.D. AKAP-Lbc nucleates a protein kinase D activation scaffold. Mol Cell 15 (2004) 889-899
78. Iwata M., Maturana A., Hoshijima M., Tatematsu K., Okajima T., Vandenheede J.R., et al. PKCepsilon-PKD1 signaling complex at Z-discs plays a pivotal role in the cardiac hypertrophy induced by G-protein coupling receptor agonists. Biochem Biophys Res Commun 327 (2005) 1105-1113
79. Iglesias T., Cabrera-Poch N., Mitchell M.P., Naven T.J., Rozengurt E., and Schiavo G. Identification and cloning of Kidins220, a novel neuronal substrate of protein kinase D. J Biol Chem 275 (2000) 40048-40056
80. Wang Y., Waldron R.T., Dhaka A., Patel A., Riley M.M., Rozengurt E., et al. The RAS effector RIN1 directly competes with RAF and is regulated by 14-3-3 proteins. Mol Cell Biol 22 (2002) 916-926
81. Hausser A., Storz P., Martens S., Link G., Toker A., and Pfizenmaier K. Protein kinase D regulates vesicular transport by phosphorylating and activating phosphatidylinositol-4 kinase IIIbeta at the Golgi complex. Nat Cell Biol 7 (2005) 880-886
82. Hinchliffe K.A., and Irvine R.F. Regulation of type II PIP kinase by PKD phosphorylation. Cell Signal 18 (2006) 1906-1913
83. Wang Y., Kedei N., Wang M., Wang Q.J., Huppler A.R., Toth A., et al. Interaction between protein kinase Cmu and the vanilloid receptor type 1. J Biol Chem 279 (2004) 53674-53682
84. Doppler H., Storz P., Li J., Comb M.J., and Toker A. A phosphorylation state-specific antibody recognizes Hsp27, a novel substrate of protein kinase D. J Biol Chem 280 (2005) 15013-15019
85. Haworth R.S., Cuello F., Herron T.J., Franzen G., Kentish J.C., Gautel M., et al. Protein kinase D is a novel mediator of cardiac troponin I phosphorylation and regulates myofilament function. Circ Res 95 (2004) 1091-1099
86. Medeiros R.B., Dickey D.M., Chung H., Quale A.C., Nagarajan L.R., Billadeau D.D., et al. Protein kinase D1 and the beta 1 integrin cytoplasmic domain control beta 1 integrin function via regulation of Rap1 activation. Immunity 23 (2005) 213-226
87. Brown R.D., Ambler S.K., Mitchell M.D., and Long C.S. The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol 45 (2005) 657-687
88. Tsybouleva N., Zhang L., Chen S., Patel R., Lutucuta S., Nemoto S., et al. Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy. Circulation 109 (2004) 1284-1291
89. Romero D.G., Welsh B.L., Gomez-Sanchez E.P., Yanes L.L., Rilli S., and Gomez-Sanchez C.E. Angiotensin II-mediated protein kinase D activation stimulates aldosterone and cortisol secretion in H295R human adrenocortical cells. Endocrinology 147 (2006) 6046-6055
90. Liljedahl M., Maeda Y., Colanzi A., Ayala I., Van L.J., and Malhotra V. Protein kinase D regulates the fission of cell surface destined transport carriers from the trans-Golgi network. Cell 104 (2001) 409-420
91. Zhukova E., Sinnett-Smith J., and Rozengurt E. Protein kinase D potentiates DNA synthesis and cell proliferation induced by bombesin, vasopressin, or phorbol esters in Swiss 3T3 cells. J Biol Chem 276 (2001) 40298-40305
92. Johannes F.J., Horn J., Link G., Haas E., Siemienski K., Wajant H., et al. Protein kinase Cmu downregulation of tumor-necrosis-factor-induced apoptosis correlates with enhanced expression of nuclear-factor-kappaB-dependent protective genes. Eur J Biochem 257 (1998) 47-54
93. Song J., Li J., Lulla A., Evers B.M., and Chung D.H. Protein kinase D protects against oxidative stress-induced intestinal epithelial cell injury via Rho/ROK/PKC-delta pathway activation. Am J Physiol Cell Physiol 290 (2006) C1469-C1476
94. 2 but not tumor necrosis factor. J Biol Chem 280 (2005) 19036-19044
95. Rykx A., De K.L., Mikhalap S., Vantus T., Seufferlein T., Vandenheede J.R., et al. Protein kinase D: a family affair. FEBS Lett 546 (2003) 81-86
96. Tobimatsu T., and Fujisawa H. Tissue-specific expression of four types of rat calmodulin-dependent protein kinase II mRNAs. J Biol Chem 264 (1989) 17907-17912
97. Rosenberg O.S., Deindl S., Sung R.J., Nairn A.C., and Kuriyan J. Structure of the autoinhibited kinase domain of CaMKII and SAXS analysis of the holoenzyme. Cell 123 (2005) 849-860
98. Hudmon A., and Schulman H. Structure-function of the multifunctional Ca2+/calmodulin-dependent protein kinase II. Biochem J 364 (2002) 593-611
99. Zhang T., Miyamoto S., and Brown J.H. Cardiomyocyte calcium and calcium/calmodulin-dependent protein kinase II: friends or foes?. Recent Prog Horm Res 59 (2004) 141-168
100. Colomer J.M., and Means A.R. Chronic elevation of calmodulin in the ventricles of transgenic mice increases the autonomous activity of calmodulin-dependent protein kinase II, which regulates atrial natriuretic factor gene expression. Mol Endocrinol 14 (2000) 1125-1136
101. Colomer J.M., Terasawa M., and Means A.R. Targeted expression of calmodulin increases ventricular cardiomyocyte proliferation and deoxyribonucleic acid synthesis during mouse development. Endocrinology 145 (2004) 1356-1366
102. Gruver C.L., DeMayo F., Goldstein M.A., and Means A.R. Targeted developmental overexpression of calmodulin induces proliferative and hypertrophic growth of cardiomyocytes in transgenic mice. Endocrinology 133 (1993) 376-388
103. Wu X., Zhang T., Bossuyt J., Li X., McKinsey T.A., Dedman J.R., et al. Local InsP3-dependent perinuclear Ca2+ signaling in cardiac myocyte excitation-transcription coupling. J Clin Invest 116 (2006) 675-682
104. Chawla S., Vanhoutte P., Arnold F.J., Huang C.L., and Bading H. Neuronal activity-dependent nucleocytoplasmic shuttling of HDAC4 and HDAC5. J Neurochem 85 (2003) 151-159
105. Linseman D.A., Bartley C.M., Le S.S., Laessig T.A., Bouchard R.J., Meintzer M.K., et al. Inactivation of the myocyte enhancer factor-2 repressor histone deacetylase-5 by endogenous Ca(2+) //calmodulin-dependent kinase II promotes depolarization-mediated cerebellar granule neuron survival. J Biol Chem 278 (2003) 41472-41481
106. Drewes G., Ebneth A., and Mandelkow E.M. MAPs, MARKs and microtubule dynamics. Trends Biochem Sci 23 (1998) 307-311
107. Drewes G. MARKing tau for tangles and toxicity. Trends Biochem Sci 29 (2004) 548-555
108. Tassan J.P., and Le G.X. An overview of the KIN1/PAR-1/MARK kinase family. Biol Cell 96 (2004) 193-199
109. Drewes G., Ebneth A., Preuss U., Mandelkow E.M., and Mandelkow E. MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption. Cell 89 (1997) 297-308
110. Dequiedt F., Martin M., Von B.J., Vertommen D., Lecomte E., Mari N., et al. New role for hPar-1 kinases EMK and C-TAK1 in regulating localization and activity of Class IIa histone deacetylases. Mol Cell Biol 26 (2006) 7086-7102
111. Biernat J., Wu Y.Z., Timm T., Zheng-Fischhofer Q., Mandelkow E., Meijer L., et al. Protein kinase MARK/PAR-1 is required for neurite outgrowth and establishment of neuronal polarity. Mol Biol Cell 13 (2002) 4013-4028
112. Cohen D., Brennwald P.J., Rodriguez-Boulan E., and Musch A. Mammalian PAR-1 determines epithelial lumen polarity by organizing the microtubule cytoskeleton. J Cell Biol 164 (2004) 717-727
113. Peng C.Y., Graves P.R., Ogg S., Thoma R.S., Byrnes III M.J., Wu Z., et al. C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding. Cell Growth Differ 9 (1998) 197-208
114. Muller J., Ory S., Copeland T., Piwnica-Worms H., and Morrison D.K. C-TAK1 regulates Ras signaling by phosphorylating the MAPK scaffold, KSR1. Mol Cell 8 (2001) 983-993
115. Bessone S., Vidal F., Le B.Y., Epelbaum J., Bluet-Pajot M.T., and Darmon M. EMK protein kinase-null mice: dwarfism and hypofertility associated with alterations in the somatotrope and prolactin pathways. Dev Biol 214 (1999) 87-101
116. Hurov J.B., Stappenbeck T.S., Zmasek C.M., White L.S., Ranganath S.H., Russell J.H., et al. Immune system dysfunction and autoimmune disease in mice lacking Emk (Par-1) protein kinase. Mol Cell Biol 21 (2001) 3206-3219
117. Goransson O., Deak M., Wullschleger S., Morrice N.A., Prescott A.R., and Alessi D.R. Regulation of the polarity kinases PAR-1/MARK by 14-3-3 interaction and phosphorylation. J Cell Sci 119 (2006) 4059-4070
118. Lizcano J.M., Goransson O., Toth R., Deak M., Morrice N.A., Boudeau J., et al. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J 23 (2004) 833-843
119. Brajenovic M., Joberty G., Kuster B., Bouwmeester T., and Drewes G. Comprehensive proteomic analysis of human Par protein complexes reveals an interconnected protein network. J Biol Chem 279 (2004) 12804-12811
120. Woods A., Johnstone S.R., Dickerson K., Leiper F.C., Fryer L.G., Neumann D., et al. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 13 (2003) 2004-2008
121. Timm T., Li X.Y., Biernat J., Jiao J., Mandelkow E., Vandekerckhove J., et al. MARKK, a Ste20-like kinase, activates the polarity-inducing kinase MARK/PAR-1. EMBO J 22 (2003) 5090-5101
122. Kosuga S., Tashiro E., Kajioka T., Ueki M., Shimizu Y., and Imoto M. GSK-3beta directly phosphorylates and activates MARK2/PAR-1. J Biol Chem 280 (2005) 42715-42722
123. Hurov J.B., Watkins J.L., and Piwnica-Worms H. Atypical PKC phosphorylates PAR-1 kinases to regulate localization and activity. Curr Biol 14 (2004) 736-741
124. Chen Y.M., Wang Q.J., Hu H.S., Yu P.C., Zhu J., Drewes G., et al. Microtubule affinity-regulating kinase 2 functions downstream of the PAR-3/PAR-6/atypical PKC complex in regulating hippocampal neuronal polarity. Proc Natl Acad Sci U S A 103 (2006) 8534-8539
125. Antos C.L., McKinsey T.A., Frey N., Kutschke W., McAnally J., Shelton J.M., et al. Activated glycogen synthase kinase-3 beta suppresses cardiac hypertrophy in vivo. Proc Natl Acad Sci U S A 99 (2002) 907-912
126. McKinsey T.A., Zhang C.L., Lu J., and Olson E.N. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408 (2000) 106-111